Technical Analysis for CTLT - Catalent, Inc.

Grade Last Price % Change Price Change
C 55.96 -0.46% -0.26
CTLT closed down 0.46 percent on Monday, March 18, 2024, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
4 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Down

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
Bollinger Band Squeeze Range Contraction -0.46%
Doji - Bullish? Reversal -0.46%
Gapped Down Weakness -0.46%
Oversold Stochastic Weakness -0.46%
Bollinger Band Squeeze Range Contraction -1.31%
Oversold Stochastic Weakness -1.31%
Bollinger Band Squeeze Range Contraction -1.13%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Catalent, Inc. Description

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment provides advanced oral delivery technologies, including formulation, development, and manufacturing of oral dose forms for prescription and consumer health products. This segment's oral dose forms include softgel, modified release technologies, and immediate release solid oral products. The Medication Delivery Solutions segment offers formulation, development, and manufacturing services for delivery of drugs and biologics administered through injection, inhalation, and ophthalmic routes. The Development and Clinical Services segment provides manufacturing, packaging, storage, and inventory management services for drugs and biologics in clinical trials. This segment also offers analytical chemical and cell-based testing and scientific services, stability testing, respiratory products formulation and manufacturing, regulatory consulting, and bioanalytical testing for biologic products. Catalent, Inc. was founded in 2007 and is headquartered in Somerset, New Jersey.


Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: S&P 500 Biotechnology Biopharmaceutical Life Sciences Pharmacy Pharmacology Health Products Ophthalmic Inventory Management Clinical Services Logic Products Biologic Products Oral Products Biologic Product Respiratory Products Catalent Consumer Health Products Inventory Management Services Softgel

Is CTLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 68.81
52 Week Low 31.45
Average Volume 3,077,660
200-Day Moving Average 46.10
50-Day Moving Average 54.46
20-Day Moving Average 57.23
10-Day Moving Average 56.53
Average True Range 0.82
RSI (14) 48.72
ADX 23.34
+DI 19.31
-DI 19.54
Chandelier Exit (Long, 3 ATRs) 56.81
Chandelier Exit (Short, 3 ATRs) 58.37
Upper Bollinger Bands 58.88
Lower Bollinger Band 55.57
Percent B (%b) 0.12
BandWidth 5.78
MACD Line 0.44
MACD Signal Line 0.85
MACD Histogram -0.416
Fundamentals Value
Market Cap 10.11 Billion
Num Shares 181 Million
EPS -7.18
Price-to-Earnings (P/E) Ratio -7.79
Price-to-Sales 2.50
Price-to-Book 2.78
PEG Ratio 3.77
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 56.92
Resistance 3 (R3) 57.01 56.77 56.76
Resistance 2 (R2) 56.77 56.53 56.73 56.71
Resistance 1 (R1) 56.37 56.38 56.25 56.28 56.65
Pivot Point 56.13 56.13 56.08 56.09 56.13
Support 1 (S1) 55.73 55.89 55.61 55.64 55.27
Support 2 (S2) 55.49 55.74 55.45 55.21
Support 3 (S3) 55.09 55.49 55.16
Support 4 (S4) 55.00